These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 31368508)
1. Cannabichromene is a cannabinoid CB Udoh M; Santiago M; Devenish S; McGregor IS; Connor M Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay. Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
6. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists. Henriquez JE; Crawford RB; Kaminski NE Toxicol Appl Pharmacol; 2019 Apr; 369():82-89. PubMed ID: 30807757 [TBL] [Abstract][Full Text] [Related]
7. Activation of CB2 Receptors by (-)-Cannabichromene but Not (+)-Cannabichromene. Udoh M; Santiago M; Haneef S; Rodger A; Marlowe CK; Barr PJ; Connor M Cannabis Cannabinoid Res; 2024 Aug; ():. PubMed ID: 39137108 [No Abstract] [Full Text] [Related]
8. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120 [TBL] [Abstract][Full Text] [Related]
9. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy. Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624 [TBL] [Abstract][Full Text] [Related]
11. Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells. Sachdev S; Boyd R; Grimsey NL; Santiago M; Connor M PeerJ; 2019; 7():e7733. PubMed ID: 31579608 [TBL] [Abstract][Full Text] [Related]
12. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats. de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434 [TBL] [Abstract][Full Text] [Related]
13. Opposite effects of cannabinoid CB Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759 [TBL] [Abstract][Full Text] [Related]
14. Absence of Entourage: Terpenoids Commonly Found in Santiago M; Sachdev S; Arnold JC; McGregor IS; Connor M Cannabis Cannabinoid Res; 2019; 4(3):165-176. PubMed ID: 31559333 [No Abstract] [Full Text] [Related]
15. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists. Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263 [TBL] [Abstract][Full Text] [Related]
16. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Deng L; Cornett BL; Mackie K; Hohmann AG Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556 [TBL] [Abstract][Full Text] [Related]
17. Regulation of cannabinoid CB Salort G; Álvaro-Bartolomé M; García-Sevilla JA Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215 [TBL] [Abstract][Full Text] [Related]
19. Activation of cannabinoid receptor 2 inhibits experimental cystitis. Wang ZY; Wang P; Bjorling DE Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R846-53. PubMed ID: 23515618 [TBL] [Abstract][Full Text] [Related]